51
Data Science Tools for Successful Technology Transfer Speakers: Thomas Zahel & Christoph Herwig 11 December 2019 ©2019 ISPE – ALL RIGHTS RESERVED

Data Science Tools for Successful Technology Transfer · 2019-12-10 · Unicorn Report Run - Formblatt Multiple spreadsheets . Projekt. QC. Email, Powerpoint, Word, Analyseauftrag

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

  • Data Science Tools for Successful Technology TransferSpeakers: Thomas Zahel & Christoph Herwig

    11 December 2019

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org

    Speaker

    Christoph Herwig, PhDProfessorVienna University of Technology

    Christoph Herwig, a bioprocess engineer from RWTH Aachen, worked in industry in the design and commissioning of large chemical facilities prior to enter his interdisciplinary PhD studies at EPFL, Switzerland in bioprocess identification. Subsequently he positioned himself at the interface between bioprocess development and facility design in biopharmaceutical industry.

    Since 2008, he is full professor for biochemical engineering at the Vienna University of Technology. The research area focuses on the development of data science methods for integrated and efficient bioprocess development along PAT and QbD principles for biopharmaceuticals. In 2013 he founded the company Exputec addressing data science solutions for the biopharma life cycle.

    2©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org

    Speaker

    Thomas Zahel, PhDHead of InnovationExputec GmbH

    Thomas Zahel is head of innovation at Exputec, with outstanding experience in statistics, algorithm development and turning complex challenges into easy concepts for our clients. His background is in bioprocess engineering and he holds a PhD in applied statistics for process development and validation. He is most passionate about developing new statistical methods that turn data into knowledge. He has successfully helped top-ranked biopharmaceutical companies to develop, improve and validate their processes according to regulatory compliance.

    3©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • BackgroundRegulatory Context of Technology Transfer

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org6

    Product Lifecycle

    Process Development

    Process Validation• Stage 1: Control Strategy• Stage 2: PPQ• Stage 3: CPV

    Commercial Production

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org7

    Product Lifecycle

    “…establish scientific evidence that a process is capable of consistently delivering quality product.“

    FDA, 2011

    Process Development

    Process Validation• Stage 1: Control Strategy• Stage 2: PPQ• Stage 3: CPV

    Commercial Production

    QRMPQS, ICH guideline Q10

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org8

    Product Lifecycle

    Process Development

    Process Validation• Stage 1: Control Strategy• Stage 2: PPQ• Stage 3: CPV

    Commercial Production

    Tech Transfer

    Tech Transfer

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org9

    Product Lifecycle

    Process Development

    Process Validation• Stage 1: Control Strategy• Stage 2: PPQ• Stage 3: CPV

    Commercial Production

    Tech Transfer

    Tech Transfer

    “The goal of technology transfer activities is to transfer product and process knowledge between development and manufacturing, and within or between manufacturing sites to achieve product realisation. This knowledge forms the basis for the manufacturing process, control strategy, process validation approach and ongoing continual improvement” ICHQ8

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org

    Present Data Science Toolswhich can be applied to the different tasks along

    technology transfer activities

    Presentation Goal

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • From Data to KnowledgeA data science route to platform based technology transfer

    using

    process mechanistic and platform knowledge

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org

    Data • Data

    Management• Data

    Contextualization• Data Integrity

    Analysis

    Information• Feature

    extraction• Scale

    independent measures

    • Soft-sensors

    Knowledge• Statistical

    comparability analysis

    • Mitigation of differences

    PV/CPV

    Success Criteria of Technology Transfer

    12©2

    019 IS

    PE – A

    LL RIG

    HTS R

    ESER

    VED

  • Connecting Pharmaceutical Knowledge ISPE.org

    Data Fusion & Data Integrity

    … features from images

    … data from PAT equipment… data from Sensors

    Process Development & Production

    … data from quality

    13©2

    019 IS

    PE – A

    LL RIG

    HTS R

    ESER

    VED

  • Connecting Pharmaceutical Knowledge ISPE.org

    We Need Structured Data: As-IsÄK-01 Äkta

    Explorer

    ÄK-02 Äkta Pilot chromatography

    skid

    ÄK-03 Äkta Explorer 100 Amersham

    LC-01 Liquid Chromatography System Äkta pure

    150 L

    LC-02 Liquid Chromatography System Äkta pure

    150 M

    LC-03 Liquid Chromatography

    System Äkta avant 150

    Projektzip

    Automated Backup

    Äkta Chromatography -

    Devices

    Backup, zum Packen

    ausgelagert

    Unicorn Report

    Run - Formblatt

    Multiple spreadsheets

    Projekt

    QCEmail, Powerpoint, Word, Analyseauftrag

    ÄK-05 Äkta Process

    Scan

    Report

    CF-03 Crossflow System Äkta Flux

    S

    USB

    Run - Formblatt

    UFDF-Sheet („Template“)Raw Data

    Projekt

    TF-01 AllegroTM Single Use TFF /

    PALL

    PALL Analytical Tool

    USBProjekt

    .chart, .sqliteDerzeit nicht ausgewertet

    Auswertung am Computer

    Report

    Chromatography

    Column Packing

    UFDF

    NF

    Run - Formblatt

    Projekt

    Buffer Prep

    Run - Formblatt

    Projekt

    Scan

    HarvestProjekt

    14©2

    019 IS

    PE – A

    LL RIG

    HTS R

    ESER

    VED

  • Connecting Pharmaceutical Knowledge ISPE.org

    We Need Structured Data: To-Be

    DB+ Analytics

    15©2

    019 IS

    PE – A

    LL RIG

    HTS R

    ESER

    VED

  • Connecting Pharmaceutical Knowledge ISPE.org

    From Data to Scale Independent Information

    0 5 10 15 20 25 30-0.02

    -0.01

    0

    0.01

    0.02

    0.03

    0.04

    0.05

    0.06

    ProcessTime (days)

    grow

    th ra

    te (1

    /hou

    rs)

    0 5 10 15 20 25 30-0.5

    0

    0.5

    1

    1.5

    2

    2.5

    3x 10

    7

    ProcessTime (days)to

    tal c

    ell c

    onc

    (cel

    ls/m

    l)

    16©2

    019 IS

    PE – A

    LL RIG

    HTS R

    ESER

    VED

  • Connecting Pharmaceutical Knowledge ISPE.org

    54321

    Make Information Ready forStatistical Analysis: Feature Extraction

    4 52.5 2.51 0.5

    t

    𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚()

    17©2

    019 IS

    PE – A

    LL RIG

    HTS R

    ESER

    VED

  • Connecting Pharmaceutical Knowledge ISPE.org

    Make Information Ready forStatistical Analysis: Unfolding

    Mercier, Sarah M., Bas Diepenbroek, Marcella C.F. Dalm, Rene H. Wijffels, and Mathieu Streefland. “Multivariate Data Analysis as a PAT Tool for Early Bioprocess Development Data.” Journal of Biotechnology, 2013. doi:10.1016/j.jbiotec.2013.07.006.

    Features = Information!

    Featuresmean, median, max, min, derivative

    Yields , qs!

    unfolding

    MVIAMVDA

    18©2

    019 IS

    PE – A

    LL RIG

    HTS R

    ESER

    VED

  • Connecting Pharmaceutical Knowledge ISPE.org

    POLL #1How do you contextualize your different data sources for doing tech transfer data analysis?

    19

    Manual alignment via Excel

    Historian data from Scada/DCS and compare process data trajectories only

    Automated process phase detection in time series and alignment of features with ELN, MES, and LIMS data

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org

    Multivariate Data Integrity Analysis (1)

    20©2

    019 IS

    PE – A

    LL RIG

    HTS R

    ESER

    VED

  • Connecting Pharmaceutical Knowledge ISPE.org

    Multivariate Data Integrity Analysis (2)

    21©2

    019 IS

    PE – A

    LL RIG

    HTS R

    ESER

    VED

  • Comparability AssessmentThe potential and practical limitations of the working horse equivalence testing

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org 23

    Comparability Assessment

    Scales Sites

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org 24

    What do we want to verify?

    CQ

    A

    pCPPtarget

    Site BSite A

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org

    Comparability Analysis

    25

    A

    C D

    B

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org

    Comparability Analysis

    26CQ

    A

    pCPP

    CQA

    pCPPtarget

    target

    CQA

    pCPPCQ

    A

    pCPPtarget

    target

    Site B

    Site AOff-setNo off-set

    Equal effect

    Different effect

    A

    C D

    B

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org

    Comparability Analysis

    27CQ

    A

    pCPP

    CQA

    pCPPtarget

    target

    CQA

    pCPPCQ

    A

    pCPPtarget

    target

    Off-setNo off-set

    Equal effect

    Different effect

    A

    C D

    BSite B

    Site A

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org 28

    Possible outcomes of comparability study for SDM

    Equivalence Test

    All responses equivalent Some responses are not equivalent

    Mitigate risk of detecteddifferences (e.g. adapt

    control strategy)A is more likely than C

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org 29

    Visual Comparison

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org

    Statistical Comparability Analysis General Workflow

    30

    2. Define general aim(non-inferiority, equivalence)

    1. Define responses for comparison (e.g. CQAs)

    3. Define measure of similarity(e.g. difference in means, ratio of variances, multivariate measure)

    4. Set EAC for each measure of similarity

    5. Calculate required sample size

    6. Perform study and conduct Statistical test on equivalence

    (e.g. TOST, F test)

    “Reflection paper on statistical methodology for the 5 comparative assessment of quality attributes in drug substance development”, EMA 2017“Comparability Protocols for Human Drugs and Biologics: Chemistry, Manufacturing, and Controls Information Guidance for Industry”, FDA 2017

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org

    Statistical Comparability Analysis General Workflow

    31

    2. Define general aim(non-inferiority, equivalence)

    1. Define responses for comparison (e.g. CQAs)

    3. Define measure of similarity(e.g. difference in means, ratio of variances, multivariate measure)

    4. Set EAC for each measure of similarity

    5. Calculate required sample size

    6. Perform study and conduct Statistical test on equivalence

    (e.g. TOST, F test)

    Use KPIs and CQAs

    Equivalence

    Set Equivalence Acceptance Criteria for eachparameter difference to be accepted

    Determine sample size for LS and SDM runs

    Perform equivalence test (i.e. TOST) foreach CQA and state practical equivalence

    Difference in means, (ratio of variances, multivariate approaches might apply)

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org

    TOST: Golden Standard for Equivalence Testing

    32

    Is 95 % of my data (difference of means) within a predefined equivalence margin?

    TOST test:1. Define equivalence

    boundaries 𝜃𝜃 = EAC2. Calculate a

    confidence interval for difference in means

    3. Check if interval is completely within upper and lower boundary.

    CI = �𝑦𝑦 ± 𝑡𝑡 1−𝛂𝛂,𝑑𝑑𝑑𝑑𝑠𝑠𝑛𝑛

    �𝑦𝑦 .. Difference in meanst .. Students T distribution𝛼𝛼 .. Desired alpha error of the test (1-confidence)𝑠𝑠 .. Standard deviation of difference of meansn .. Sample size

    1 − 𝛼𝛼 makes CI broader

    n makes CI more narrow

    𝑦𝑦1 + 𝑦𝑦2 ± 𝑡𝑡 1−𝛼𝛼,𝑑𝑑𝑑𝑑𝑠𝑠1²𝑚𝑚1

    +𝑠𝑠2²𝑚𝑚2©2

    019 IS

    PE – A

    LL RIG

    HTS R

    ESER

    VED

  • Connecting Pharmaceutical Knowledge ISPE.org 33

    Equivalence Test Result

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org 34

    Possible outcomes of comparability study for SDM

    Equivalence Test

    All responses equivalent Some responses are not equivalent

    Mitigate risk of detecteddifferences (e.g. adapt

    control strategy)A is more likely than C

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org

    POLL #2For comparability tests between scales and sites I use?

    35

    Visual comparison

    Golden batch comparison of process data trajectories using fixed standard deviations

    Endpoints of quality data from LIMS

    Univariate TOST approaches

    Multivariate analysis, e.g. Hotelling’s T² test or PCA

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Mitigate Differences in Technology Transfer using Integrated Process ModelsA holistic approach to control strategy

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org 37

    Data Sources

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org 38

    Data Sources

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org 39

    Data Sources

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org 40

    Data Sources

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org 41

    Digital Twin

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org 42

    What Does it Do?

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org 43

    How Does it Work?

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org 44

    How Does it Work?

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org 45

    What Does it Look Like?

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org 46

    Holistic Risk Assessment

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org

    47

    How to Set a Control Strategy using an IPM?

    UO 1 UO 2 UO 3 UO 4 UO 5 UO 6 UO 7 DS

    3.2 4

    DSDS

    CQA

    Elution pH

    Load Density

    14 24

    Upper PAR

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org

    POLL #3For testing success tech transfer and valid control strategies of the full process chain, I use:

    48

    Comparison of single unit operations only

    Multitude of linkage studies to demonstrate elasticity of the process along perturbations onside of the control strategy

    Integrated modelling approach to focus on holistically critical process parameters and limit the number of experiments

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org

    • From mess to structure• Sound implementation of data management tools is key to data analytics• Tools exist that leverage all possible kind of data (timeseries, pictures, scalar values, …)

    • From data to information• Feature extraction based on process understanding enables robust multivariate

    information analysis• From information to knowledge

    • Statistical comparability analysis forms risk awareness about similarities and differences• Integrated process modelling is essential to derive a control strategy based on holistic

    process performance

    Conclusions:Successful tech transfer using data science tools

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Q&A

    ©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

  • Connecting Pharmaceutical Knowledge ISPE.org

    Q&A

    51

    Contact Information

    Christoph Herwig, PhDProfessor, Vienna University of [email protected]

    Thomas Zahel, PhDHead of Innovation, Exputec [email protected]

    Upcoming Webinars• 23 January - One Size Does Not Fit All:

    Strategies for Bringing Advanced Therapy Medicinal Products to Market

    Topic Ideas or Feedback? Send to [email protected]

    51©2019

    ISPE

    – ALL

    RIGHT

    S RES

    ERVE

    D

    mailto:[email protected]:[email protected]

    Data Science Tools for Successful Technology TransferSpeaker��Christoph Herwig, PhD�Professor�Vienna University of TechnologySpeaker��Thomas Zahel, PhD�Head of Innovation�Exputec GmbHSlide Number 4BackgroundProduct LifecycleProduct LifecycleProduct LifecycleProduct LifecyclePresentation GoalFrom Data to KnowledgeSuccess Criteria of Technology TransferData Fusion & Data IntegrityWe Need Structured Data: As-IsWe Need Structured Data: To-BeFrom Data to Scale Independent InformationMake Information Ready for�Statistical Analysis: Feature ExtractionMake Information Ready for�Statistical Analysis: UnfoldingPOLL #1Multivariate Data Integrity Analysis (1)Multivariate Data Integrity Analysis (2)Comparability AssessmentComparability AssessmentWhat do we want to verify?Comparability AnalysisComparability AnalysisComparability AnalysisPossible outcomes of comparability study for SDMVisual ComparisonStatistical Comparability Analysis General WorkflowStatistical Comparability Analysis General WorkflowTOST: Golden Standard for Equivalence TestingEquivalence Test ResultPossible outcomes of comparability study for SDMPOLL #2Mitigate Differences in Technology Transfer using Integrated Process ModelsData SourcesData SourcesData SourcesData SourcesDigital TwinWhat Does it Do?How Does it Work?How Does it Work?What Does it Look Like?Holistic Risk AssessmentHow to Set a Control Strategy using an IPM?POLL #3Conclusions:�Successful tech transfer using data science toolsQ&A Q&A